# Interventional Study of Wellbutrin XL in Major Depressive Disorder With Atypical Features

> **NCT01477931** · PHASE4 · COMPLETED · sponsor: **Chi-Un Pae** · enrollment: 50 (actual)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DRUG:** Bupropion extended release

## Key facts

- **NCT ID:** NCT01477931
- **Lead sponsor:** Chi-Un Pae
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-07
- **Final completion:** 2011-09
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2011-11-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01477931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01477931, "Interventional Study of Wellbutrin XL in Major Depressive Disorder With Atypical Features". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01477931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*